Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results

Click here to go back to your search results.

Breast Cancer treatment details. Chemotherapy. Uludag University Medical School, Bursa, Turkey

Survival: 14.5 months
Toxicity Grade: 4
Treatments: Chemotherapy
Drugs: Gemzar
Country: Turkey
City/State/Province: Bursa
Hospital: Uludag University Medical School
Journal: Link
Date: 11/2005

Patients: This Phase II study involved 26 women with metastatic breast cancer. The mean age was 47.3 years. Metastatic sites included bone, liver, and lung. All women had prior anthracycline adjuvant chemotherapy before this study.

Treatment: The treatment consisted of two chemotherapeutic agents: gemcitabine and paclitaxel.

Toxicity: Grade 3-4 toxicities included neutropenia, thrombocytopenia, anemia, nausea/vomiting, and allergies.

Results: The median overall survival was 14.5 months. The authors concluded, "gemcitabine plus paclitaxel combination is an effective and safe regimen in anthracycline pretreated metastatic breast cancer."

Correspondence: Mutlu Demiray

E-mail to a Friend Email Physician More Information